IL6 and rheumatoid arthritis: Previous studies have shown that inhibiting TNF-α in RA reduces local osteoarthritis through a reduction in synovial cell infiltration and the expression of adhesion molecules, chemokines, and cytokines, coinciding with reduced levels of acute phase reactants such as CRP and interleukin (IL)-6 [28].